Syndopa 275 mg Sun Pharmaceuticals Industries
| Features | |
| Also known as | L-DOPA |
| Blood pressure | Can cause orthostatic hypotension |
| Chemical name | L-3,4-dihydroxyphenylalanine |
| Dosage (medical) | Typically, initial doses are 100 mg daily, increasing gradually as needed and tolerated. Maintenance doses usually range from 300 mg to 800 mg per day, divided into multiple doses |
| Dosage (sports) | Not applicable as it is not used for enhancing sports performance |
| Effects | Improves motor control and reduces symptoms of Parkinson's disease |
| Formula | C9H11NO4 |
| Half-life | 1 to 3 hours |
| Hepatotoxicity | Low to none |
| Lab Test | Monitoring of liver and kidney functions may be recommended |
| Main action | Precursor to dopamine, used to increase dopamine concentrations in the treatment of Parkinson's disease and dopamine-responsive dystonia |
| Side effects | Nausea, vomiting, hypotension, dyskinesias, hallucinations, dizziness, and confusion |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Strength | 275 mg |
| Substance class | Amino acid derivative |
| Trade name | Sinemet, Levodopa, Dopar |
| Use in sports | Not typically used in sports, considered doping if used to enhance performance |
| Water Retention | Minimal to none |
| Manufacturer | Sun Pharmaceuticals Industries |